參考文獻/References:
[1] MOTYL K J,GUNTUR A R,CARVALHO A L,et al.Energy metabolism of bone[J].Toxicol Pathol,2017,45(7):887-893.
[2] BOSC D G,GRAHAM K C,SAULNIER R B,et al.Identification and characterization of CKIP-1,a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2[J].J Biol Chem,2000,275(19):14295-14306.
[3] OZDAMAR B,BOSE R,BARRIOS-RODILES M,et al.Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity[J].Science,2005,307(5715):1603-1609.
[4] PENG X,WU X,ZHANG J,et al.The role of CKIP-1 in osteoporosis development and treatment[J].Bone Joint Res,2018,7(2):173-178.
[5] LU K,YIN X,WENG T,et al.Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1[J].Nat Cell Biol,2008,10(8):994-1002.
[6] LIU J,LU C,WU X,et al.Targeting osteoblastic casein kinase-2 interacting protein-1 to enhance Smad-dependent BMP signaling and reverse bone formation reduction in glucocorticoid-induced osteoporosis[J].Sci Rep,2017,7:41295.
[7] HUANG X,LIANG J,GAO Y,et al.Ckip-1 regulates C3H10T1/2 mesenchymal cell proliferation and osteogenic differentiation via Lrp5[J].Exp Ther Med,2021,21(4):342.
[8] 梁建飛.下調Ckip-1通過骨形成相關信號通路促進MSCs增殖及成骨分化的作用研究[D].西安:第四軍醫(yī)大學,2017.
[9] GREENHILL C.Bone:autophagy regulates bone growth in mice[J].Nat Rev Endocrinol,2016,12(1):4.
[10] BO T,YAN F,GUO J,et al.Characterization of a relatively malignant form of osteopetrosis caused by a novel mutation in the PLEKHM1 gene[J].J Bone Miner Res,2016,31(11):1979-1987.
[11] WU Q,ZHONG Z M,PAN Y,et al.Advanced oxidation protein products as a novel marker of oxidative stress in post-menopausal osteoporosis[J].Med Sci Monit,2015,21:2428-2432.
[12] 楊依然.CKIP-1介導mTOR通路對絕經(jīng)后骨質疏松癥致病機理及強骨飲對其干預的研究[D].杭州:浙江中醫(yī)藥大學,2021.
[13] PARZYCH K R,KLIONSKY D J.An overview of auto-phagy:morphology,mechanism,and regulation[J].Antioxid Redox Signal,2014,20(3):460-473.
[14] CUERVO A M,WONG E.Chaperone-mediated auto-phagy:roles in disease and aging[J].Cell Res,2014,24(1):92-104.
[15] MIZUSHIMA N,KOMATSU M.Autophagy:renovation of cells and tissues[J].Cell,2011,147(4):728-741.
[16] BEGUN J,XAVIER R J.Autophagy at the crossroads of metabolism and cellular defense[J].Curr Opin Gastroenterol,2013,29(6):588-596.
[17] SARPARANTA J,GARCÍA-MACIA M,SINGH R.Autophagy and mitochondria in obesity and type 2 diabetes[J].Curr Diabetes Rev,2017,13(4):352-369.
[18] REVUELTA M,MATHEU A.Autophagy in stem cell aging[J].Aging Cell,2017,16(5):912-915.
[19] PIERREFITE-CARLE V,SANTUCCI-DARMANIN S,BREUIL V,et al.Autophagy in bone:self-eating to stay in balance[J].Ageing Res Rev,2015,24(Pt B):206-217.
[20] NIXON R A.The role of autophagy in neurodegenerative disease[J].Nat Med,2013,19(8):983-997.
[21] CHAGIN A S.Effectors of mTOR-autophagy pathway:targeting cancer,affecting the skeleton[J].Curr Opin Pharmacol,2016,28:1-7.
[22] ENGELMAN J A,LUO J,CANTLEY L C.The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism[J].Nat Rev Genet,2006,7(8):606-619.
[23] BACKER J M.The intricate regulation and complex functions of the Class Ⅲ phosphoinositide 3-kinase Vps34[J].Biochem J,2016,473(15):2251-2271.
[24] DE SANTIS M C,GULLUNI F,CAMPA C C,et al.Targeting PI3K signaling in cancer:challenges and advances[J].Biochim Biophys Acta Rev Cancer,2019,1871(2):361-366.
[25] ALESSI D R,JAMES S R,DOWNES C P,et al.Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha[J].Curr Biol,1997,7(4):261-269.
[26] HUANG J,MANNING B D.A complex interplay between Akt,TSC2 and the two mTOR complexes[J].Biochem Soc Trans,2009,37(Pt 1):217-222.
[27] KIM J,KUNDU M,VIOLLET B,et al.AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1[J].Nat Cell Biol,2011,13(2):132-141.
[28] ZACHARI M,GANLEY I G.The mammalian ULK1 complex and autophagy initiation[J].Essays Biochem,2017,61(6):585-596.
[29] CHEN Y,HE J,TIAN M,et al.UNC51-like kinase 1,autophagic regulator and cancer therapeutic target[J].Cell Prolif,2014,47(6):494-505.
[30] XI G,ROSEN C J,CLEMMONS D R.IGF-I and IGFBP-2 stimulate AMPK activation and autophagy,which are required for osteoblast differentiation[J].Endocrinology,2016,157(1):268-281.
[31] LIU F,FANG F,YUAN H,et al.Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation[J].J Bone Miner Res,2013,28(11):2414-2430.
[32] NOLLET M,SANTUCCI-DARMANIN S,BREUIL V,et al.Autophagy in osteoblasts is involved in mineralization and bone homeostasis[J].Autophagy,2014,10(11):1965-1977.
[33] VUPPALAPATI K K,BOUDERLIQUE T,NEWTON P T,et al.Targeted deletion of autophagy genes Atg5 or Atg7 in the chondrocytes promotes caspase-dependent cell death and leads to mild growth retardation[J].J Bone Miner Res,2015,30(12):2249-2261.
[34] SHIN N Y,CHOI H,NEFF L,et al.Dynamin and endocytosis are required for the fusion of osteoclasts and myoblasts[J].J Cell Biol,2014,207(1):73-89.
[35] DESELM C J,MILLER B C,ZOU W,et al.Autophagy proteins regulate the secretory component of osteoclastic bone resorption[J].Dev Cell,2011,21(5):966-974.
[36] LIN N Y,CHEN C W,KAGWIRIA R,et al.Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss[J].Ann Rheum Dis,2016,75(6):1203-1210.
[37] 米健國,喬榮勤,劉少津.補腎健脾活血方干預骨質疏松模型大鼠骨代謝、氧化應激及自噬的變化[J].中國組織工程研究,2022,26(26):4147-4152.
[38] 招文華,任輝,沈耿楊,等.mTORC1抑制自噬調控Wnt/β-catenin信號通路在激素環(huán)境下對MC3T3-E1成骨分化的影響[J].中國骨質疏松雜志,2022,28(1):16-20.
[39] 李希寧,董穎,趙宇,等.雷帕霉素通過抑制mTOR通路激活自噬緩解氟骨癥大鼠早期的骨質疏松[J].中華勞動衛(wèi)生職業(yè)病雜志,2021,39(5):321-327.
[40] BOSC D G,GRAHAM K C,SAULNIER R B,et al.Identification and characterization of CKIP-1,a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2[J].J Biol Chem,2000,275(19):14295-14306.
[41] OZDAMAR B,BOSE R,BARRIOS-RODILES M,et al.Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity[J].Science,2005,307(5715):1603-1609.
[42] FU L,ZHANG L.Physiological functions of CKIP-1:from molecular mechanisms to therapy implications[J].Ageing Res Rev,2019,53:100908.
[43] ZHANG G,GUO B,WU H,et al.A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy[J].Nat Med,2012,18(2):307-314.
[44] LIU J,LIANG C,GUO B,et al.Increased PLEKHO1 within osteoblasts suppresses smad-dependent BMP signaling to inhibit bone formation during aging[J].Aging Cell,2017,16(2):360-376.
[45] LIU J,LU C,WU X,et al.Targeting osteoblastic casein kinase-2 interacting protein-1 to enhance smad-dependent BMP signaling and reverse bone formation reduction in glucocorticoid-induced osteoporosis[J].Sci Rep,2017,7:41295.
[46] HUANG X,LIANG J,GAO Y,et al.Ckip-1 regulates C3H10T1/2 mesenchymal cell proliferation and osteogenic differentiation via Lrp5[J].Exp Ther Med,2021,21(4):342.
[47] TOKUDA E,FUJITA N,OH-HARA T,et al.Casein kinase 2-interacting protein-1,a novel Akt pleckstrin homology domain-interacting protein,down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo[J].Cancer Res,2007,67(20):9666-9676.
[48] YUAN Y,SUN J,ZHOU H,et al.The effect of QiangGuYin on osteoporosis through the AKT/mTOR/autophagy signaling pathway mediated by CKIP-1[J].Aging(Albany NY),2022,14(2):892-906.
中醫(yī)正骨2022年6月第34卷第6期 J Trad Chin Orthop Trauma,2022,Vol.34,No.6(總461)
(總462)中醫(yī)正骨2022年6月第34卷第6期 J Trad Chin Orthop Trauma,2022,Vol.34,No.6
[49] ZHANG L,WANG Y,XIAO F,et al.CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation[J].Cell Res,2014,24(6):742-761.
[50] LUO D,REN H,LI T,et al.Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy[J].Osteoporos Int,2016,27(3):1093-1101.
[51] YIN Z Y,YIN J,HUO Y F,et al.Rapamycin facilitates fracture healing through inducing cell autophagy and suppressing cell apoptosis in bone tissues[J].Eur Rev Med Pharmacol Sci,2017,21(21):4989-4998.
[52] SHEN G,REN H,SHANG Q,et al.Autophagy as a target for glucocorticoid-induced osteoporosis therapy[J].Cell Mol Life Sci,2018,75(15):2683-2693.
[53] HAN Y,ZHANG L,XING Y,et al.Autophagy relieves the function inhibition and apoptosis-promoting effects on osteoblast induced by glucocorticoid[J].Int J Mol Med,2018,41(2):800-808.
相似文獻/References:
[1]李林軍.應用膨脹式椎弓根螺釘內固定治療合并骨質疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):7.
[3]李學朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):12.
[4]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術中的應用[J].中醫(yī)正骨,2015,27(02):40.
[5]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):27.
[6]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):19.
[7]項旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質疏松與血微量元素的關系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):20.
[8]史曉林,李春雯,張志強.弱陽離子磁珠分離技術和基質輔助激光解吸電離飛行時間質譜技術在原發(fā)性Ⅰ型骨質疏松癥血清標志蛋白篩選中的應用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):5.
[9]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):21.
[10]陳俊杰,李晴晴,夏瑢.脂代謝及血清內脂素水平與絕經(jīng)后骨質疏松癥的
相關性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(06):16.